133 related articles for article (PubMed ID: 30833018)
41. Enhanced insulin production and reprogramming efficiency of mesenchymal stem cells derived from porcine pancreas using suitable induction medium.
Lee S; Moon S; Oh JY; Seo EH; Kim YH; Jun E; Shim IK; Kim SC
Xenotransplantation; 2019 Jan; 26(1):e12451. PubMed ID: 30252163
[TBL] [Abstract][Full Text] [Related]
42. PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells.
Abazari MF; Soleimanifar F; Nouri Aleagha M; Torabinejad S; Nasiri N; Khamisipour G; Amini Mahabadi J; Mahboudi H; Enderami SE; Saburi E; Hashemi J; Kehtari M
Gene; 2018 Sep; 671():50-57. PubMed ID: 29860065
[TBL] [Abstract][Full Text] [Related]
43. Sweet Relief: Reprogramming Gastric Endocrine Cells to Make Insulin.
McCauley HA; Wells JM
Cell Stem Cell; 2016 Mar; 18(3):295-7. PubMed ID: 26942844
[TBL] [Abstract][Full Text] [Related]
44. Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells.
Jian RL; Mao LB; Xu Y; Li XF; Wang FP; Luo XG; Zhou H; He HP; Wang N; Zhang TC
Gene; 2015 May; 562(1):107-16. PubMed ID: 25724395
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
Domouky AM; Hegab AS; Al-Shahat A; Raafat N
Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
[TBL] [Abstract][Full Text] [Related]
46. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
Vanikar AV; Trivedi HL; Thakkar UG
Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
[TBL] [Abstract][Full Text] [Related]
47. Strategies to generate induced pluripotent stem cells.
Hayes M; Zavazava N
Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
[TBL] [Abstract][Full Text] [Related]
48. Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro.
He D; Wang J; Gao Y; Zhang Y
Int J Mol Med; 2011 Dec; 28(6):1019-24. PubMed ID: 21837359
[TBL] [Abstract][Full Text] [Related]
49. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
Sharma A; Rani R
Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
[TBL] [Abstract][Full Text] [Related]
50. Induction of insulin-producing cells from human pancreatic progenitor cells.
Noguchi H; Naziruddin B; Shimoda M; Fujita Y; Chujo D; Takita M; Peng H; Sugimoto K; Itoh T; Tamura Y; Olsen GS; Kobayashi N; Onaca N; Hayashi S; Levy MF; Matsumoto S
Transplant Proc; 2010; 42(6):2081-3. PubMed ID: 20692413
[TBL] [Abstract][Full Text] [Related]
51. Generation of insulin-producing cells from human induced pluripotent stem cells on PLLA/PVA nanofiber scaffold.
Enderami SE; Kehtari M; Abazari MF; Ghoraeian P; Nouri Aleagha M; Soleimanifar F; Soleimani M; Mortazavi Y; Nadri S; Mostafavi H; Askari H
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1062-1069. PubMed ID: 29486602
[TBL] [Abstract][Full Text] [Related]
52. Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media.
Fukuta M; Nakai Y; Kirino K; Nakagawa M; Sekiguchi K; Nagata S; Matsumoto Y; Yamamoto T; Umeda K; Heike T; Okumura N; Koizumi N; Sato T; Nakahata T; Saito M; Otsuka T; Kinoshita S; Ueno M; Ikeya M; Toguchida J
PLoS One; 2014; 9(12):e112291. PubMed ID: 25464501
[TBL] [Abstract][Full Text] [Related]
53. [From stem cells to functional beta cells in type 1 diabetes].
Engberg N; Hansson M; Madsen OD
Ugeskr Laeger; 2010 Sep; 172(38):2608-12. PubMed ID: 20920405
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic stem cells differentiate into insulin-secreting cells on fibroblast-modified PLGA membranes.
Tan J; Liu L; Li B; Xie Q; Sun J; Pu H; Zhang L
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():593-601. PubMed ID: 30678946
[TBL] [Abstract][Full Text] [Related]
55. In vitro evaluation of different protocols for the induction of mesenchymal stem cells to insulin-producing cells.
Seyedi F; Farsinejad A; Moshrefi M; Nematollahi-Mahani SN
In Vitro Cell Dev Biol Anim; 2015 Sep; 51(8):866-78. PubMed ID: 25898825
[TBL] [Abstract][Full Text] [Related]
56. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
[TBL] [Abstract][Full Text] [Related]
57. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.
Xie QP; Huang H; Xu B; Dong X; Gao SL; Zhang B; Wu YL
Differentiation; 2009 Jun; 77(5):483-91. PubMed ID: 19505629
[TBL] [Abstract][Full Text] [Related]
58. ROCKII inhibition promotes the maturation of human pancreatic beta-like cells.
Ghazizadeh Z; Kao DI; Amin S; Cook B; Rao S; Zhou T; Zhang T; Xiang Z; Kenyon R; Kaymakcalan O; Liu C; Evans T; Chen S
Nat Commun; 2017 Aug; 8(1):298. PubMed ID: 28824164
[TBL] [Abstract][Full Text] [Related]
59. Three-dimensional differentiation of adipose-derived mesenchymal stem cells into insulin-producing cells.
Khorsandi L; Khodadadi A; Nejad-Dehbashi F; Saremy S
Cell Tissue Res; 2015 Sep; 361(3):745-53. PubMed ID: 25795142
[TBL] [Abstract][Full Text] [Related]
60. Making β cells from adult tissues.
Efrat S; Russ HA
Trends Endocrinol Metab; 2012 Jun; 23(6):278-85. PubMed ID: 22537825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
